Table 1.
Number (%) | Allelic Association | ||||||
---|---|---|---|---|---|---|---|
Genotype | GG | GT | TT | Total | G Allele | p-Value | OR (95% CI) |
control | 7 (1.3) | 119 (22.8) | 397 (75.9) | 523 | 133 (12.7) | - | - |
SSc | 10 (2.7) | 82 (22.5) | 273 (74.8) | 365 | 102 (14.0) | 0.442 | 1.12 (0.85-1.47) |
dcSSc | 4 (2.3) | 36 (20.6) | 135 (77.1) | 175 | 44 (12.6) | 0.944 | 0.99 (0.69-1.42) |
lcSSc | 4 (3.1) | 30 (23.1) | 96 (73.8) | 130 | 38 (14.6) | 0.417 | 1.18 (0.80-1.73) |
ATA+ | 4 (2.5) | 37 (23.6) | 116 (73.9) | 157 | 45 (14.3) | 0.457 | 1.15 (0.80-1.65) |
ACA+ | 1 (2.3) | 7 (16.3) | 35 (81.4) | 43 | 9 (10.5) | 0.546 | 0.80 (0.39-1.64) |
PF | 6 (3.0) | 40 (20.2) | 152 (76.8) | 198 | 52 (13.1) | 0.833 | 1.04 (0.74-1.46) |
ATA = anti-topoisomerase I autoantibodies; ACA = anti-centromere autoantibodies; PF = pulmonary fibrosis; p = p value; OR = odds ratio; CI = confidence interval.